ZNTL earnings: real EPS beat/miss history, analyst consensus Buy, P/E -2.60. Updated 2026-07-23.
Zentalis Pharmaceuticals (ZNTL) Research Hub
Zentalis Pharmaceuticals (ZNTL) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 3.51 USD (-7.63%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.60, market cap 0.31B. This hub links to the full technical, earnings and options research available for ZNTL.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.51 USD (-7.63%) |
| 52-week range | 3.465 USD – 5.58 USD |
| Trend regime | Range |
| 14-day RSI | 32.5 (Bearish) |
| Trailing P/E | -2.60 |
| Market cap | 0.31B |
| Dividend yield | 0.00% |
Available research for ZNTL
Covered Call on ZNTL: how it works, illustrative setup around the real 3.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ZNTL: how it works, illustrative setup around the real 3.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ZNTL: how it works, illustrative setup around the real 3.51 USD price, max profit/loss, breakeven and when to use it. Educational.
ZNTL technical analysis: range, last 3.51 USD, RSI 32.5, 52w range 3.465 USD–5.58 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ZNTL in?
Zentalis Pharmaceuticals (ZNTL) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ZNTL in an uptrend or downtrend?
As of 2026-09-11, ZNTL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ZNTL's trailing P/E ratio?
ZNTL's trailing P/E is -2.60, with a market cap of 0.31B. See the earnings research page for full valuation detail.